For men aged 50-69 years who underwent a one-time prostate-specific antigen (PSA) screening for prostate cancer, a lower prostate cancer-specific mortality was observed after 15 years of follow-up, ...
Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining treatment with PARP inhibitors. Precision medicine has revolutionized the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback